论文部分内容阅读
Objective: Hepatectomy is associated with high rates of postoperative live dysfunction in patients with cirrhosis.Since S-adenosyl-L-methionine (SAMe) can be used to treat liver disease,we performed a prospective clinical trial to investigate whether itcould be used after hepatectomy to benefit residual liver function.